- Home
- VERU vs NAMM Comparison
VERU vs NAMM Comparison
Compare VERU & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VERU | NAMM |
|---|---|---|
| Founded | 1971 | 2024 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 49.4M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | VERU | NAMM |
|---|---|---|
| Price | $2.62 | $3.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $22.50 | N/A |
| AVG Volume (30 Days) | 65.5K | ★ 2.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,296,958.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.93 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.36 | $0.91 |
| 52 Week High | $4.59 | $27.78 |
Technical Indicators
Market Signals| Indicator | VERU | NAMM |
|---|---|---|
| Relative Strength Index (RSI) | 55.32 | 51.17 |
| Support Level | $2.15 | $2.67 |
| Resistance Level | $2.77 | $3.75 |
| Average True Range (ATR) | 0.16 | 0.54 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 79.17 | 50.00 |
Price Performance
Historical ComparisonAbout VERU Veru Inc.
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
About NAMM Namib Minerals Ordinary Shares
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.